Topically administered macrocyclic lactone products, including eprinomectin, demonstrate comparable neurological safety in cats based on pharmacovigilance data
These findings supported the conclusion that ML-containing products (including eprinomectin-containing products) and emodepside are comparable in the frequencies and types of neurological AEs associated with feline topical parasiticide products described as substrates for P-glycoprotein transporters.
Authors
- Timothy S. Frana
- Mark J. Novotny (ORCID: https://orcid.org/0000-0002-0288-1599)
- Timothy G. Geary
- Marcelo Silva
Institutions
- Université Sainte-Anne (CA)
- Queen's University Belfast (GB)
- Boehringer Ingelheim (Germany) (DE)
- Boehringer Ingelheim (United States) (US)
- McGill University (CA)
Publication Details
- Journal
- Journal of the American Veterinary Medical Association
- Published
- 2026-01-09
- DOI
- https://doi.org/10.2460/javma.25.10.0669
- Primary Topic
- Helminth infection and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00